Publications by authors named "Solaiappan Manimaran"

Article Synopsis
  • - This study evaluated the effects of sotatercept on exercise tolerance, capacity, and right ventricular function in patients with pulmonary arterial hypertension through the SPECTRA clinical trial.
  • - Results showed that out of 21 participants, there was a significant increase in peak oxygen uptake after 24 weeks of treatment, along with improvements in exercise hemodynamics and walking distance.
  • - The findings suggest that sotatercept could be a promising new treatment option for pulmonary arterial hypertension, potentially reversing heart function decline.
View Article and Find Full Text PDF
Article Synopsis
  • Sotatercept is a new protein being developed to treat pulmonary arterial hypertension (PAH) by inhibiting activin signaling, and it was tested in a phase III clinical trial called STELLAR.
  • In the study, 162 participants were treated either with sotatercept or a placebo, and about 25.9% developed antidrug antibodies (ADAs), with a small percentage also showing neutralizing antibodies.
  • The presence of ADAs did not significantly impact the drug's effectiveness, safety, or how the body processed the drug, indicating that sotatercept remains a viable treatment option for patients with PAH.
View Article and Find Full Text PDF
Article Synopsis
  • In a study on pulmonary arterial hypertension, 24 weeks of sotatercept showed a significant decrease in pulmonary vascular resistance compared to a placebo, prompting further investigation into its long-term effects over 18-24 months.
  • The PULSAR study involved a randomized, double-blind, placebo-controlled design, where participants receiving placebo were switched to sotatercept, while others who started on sotatercept continued their treatment to evaluate its safety and efficacy.
  • Results indicated that 30.8% of participants experienced serious side effects, but overall, sotatercept demonstrated sustained clinical benefits and safety, with significant improvements noted in both primary and secondary efficacy endpoints.
View Article and Find Full Text PDF
Article Synopsis
  • Pulmonary arterial hypertension (PAH) involves changes in lung blood vessels and poor outcomes, and the novel drug sotatercept aims to fix dysfunctional signaling in this process.* -
  • In a 24-week study with 106 participants, those receiving sotatercept showed significant improvements in pulmonary vascular resistance compared to the placebo group, particularly at dosages of 0.3 mg and 0.7 mg.* -
  • While sotatercept improved exercise capacity and reduced certain biomarkers, common side effects included lowered platelet count and increased hemoglobin, with one serious adverse event reported.*
View Article and Find Full Text PDF

Background: Microbial communities that live in and on the human body play a vital role in health and disease. Recent advances in sequencing technologies have enabled the study of microbial communities at unprecedented resolution. However, these advances in data generation have presented novel challenges to researchers attempting to analyze and visualize these data.

View Article and Find Full Text PDF

Maternal immune activation (MIA) disrupts the central innate immune system during a critical neurodevelopmental period. Microglia are primary innate immune cells in the brain although their direct influence on the MIA phenotype is largely unknown. Here we show that MIA alters microglial gene expression with upregulation of cellular protrusion/neuritogenic pathways, concurrently causing repetitive behavior, social deficits, and synaptic dysfunction to layer V intrinsically bursting pyramidal neurons in the prefrontal cortex of mice.

View Article and Find Full Text PDF

Background: Combining genomic data sets from multiple studies is advantageous to increase statistical power in studies where logistical considerations restrict sample size or require the sequential generation of data. However, significant technical heterogeneity is commonly observed across multiple batches of data that are generated from different processing or reagent batches, experimenters, protocols, or profiling platforms. These so-called batch effects often confound true biological relationships in the data, reducing the power benefits of combining multiple batches, and may even lead to spurious results in some combined studies.

View Article and Find Full Text PDF

Unlabelled: Sequencing and microarray samples often are collected or processed in multiple batches or at different times. This often produces technical biases that can lead to incorrect results in the downstream analysis. There are several existing batch adjustment tools for '-omics' data, but they do not indicate a priori whether adjustment needs to be conducted or how correction should be applied.

View Article and Find Full Text PDF

Background: The relationships between infections in early life and asthma are not completely understood. Likewise, the clinical relevance of microbial communities present in the respiratory tract is only partially known. A number of microbiome studies analyzing respiratory tract samples have found increased proportions of gamma-Proteobacteria including Haemophilus influenzae, Moraxella catarrhalis, and Firmicutes such as Streptococcus pneumoniae.

View Article and Find Full Text PDF
Article Synopsis
  • * PathoScope 2.0 is introduced as a comprehensive bioinformatics framework that effectively quantifies the presence of specific microbial strains in metagenomic data, preparing and analyzing data through several essential computational steps.
  • * Evaluation of PathoScope 2.0 indicates it is more sensitive and efficient compared to other methods, making it a valuable tool for metagenomic analysis. The software is freely accessible for researchers.
View Article and Find Full Text PDF
Article Synopsis
  • Clinical PathoScope
  • is a new tool designed to enhance patient healthcare by accurately identifying pathogens in microbiome samples, which often contain genetic material from multiple sources, complicating the identification process.
  • - The pipeline successfully isolates microbial reads, identifies multiple pathogens in a sample, and recognizes pathogens at the subspecies level, proving superior in speed, sensitivity, and specificity compared to traditional methods.
  • - Unlike other identification techniques that require genome assembly, Clinical PathoScope allows for faster analysis of clinical samples and is freely accessible online for researchers and clinicians.
View Article and Find Full Text PDF

Quality control and read preprocessing are critical steps in the analysis of data sets generated from high-throughput genomic screens. In the most extreme cases, improper preprocessing can negatively affect downstream analyses and may lead to incorrect biological conclusions. Here, we present PathoQC, a streamlined toolkit that seamlessly combines the benefits of several popular quality control software approaches for preprocessing next-generation sequencing data.

View Article and Find Full Text PDF
Article Synopsis
  • Next-generation sequencing technologies are transforming genomic data collection for bioforensics, biosurveillance, and clinical use, requiring new methods to efficiently analyze large data volumes.
  • The proposed statistical framework, Pathoscope, utilizes a Bayesian approach to rapidly identify species and strains from environmental or tissue samples while factoring in sequence quality and the possibility of multiple species present.
  • Pathoscope can distinguish closely related strains with minimal genome coverage, avoiding labor-intensive steps like alignment and assembly, and has shown effectiveness in analyzing data from known bacterial agents relevant to human health.
View Article and Find Full Text PDF